Enterprise leaders say recipe for AI agents is matching them to existing processes — not the other way around

Eamily Evans
By Eamily Evans
Block Chain

Share This Post



Global enterprises Block and GlaxoSmithKline (GSK) are exploring AI agent proof of concepts in financial services and drug discovery. Read More



Source link

spot_img

Related Posts

This Jammer Wants to Block Always-Listening AI Wearables. It Probably Won’t Work

Deveillance also claims the Spectre can find nearby...

eBay Is Selling a Cornucopia of Russian Peptides

Sign up to see the future, today ...

Regulating internet is Centre’s domain, social media ban imposed by A.P., Karnataka may hit jurisdictional barrier

Marvell Tech shares soar on bullish multi-year AI chip outlook

Marvell Technology rose nearly 11% in early trading...

Access Denied

Access Denied You don't have permission to access...

Women’s Day gift guide: Beauty and wellness tech worth considering

International Women’s Day is celebrated on March 8...
spot_img
Previous article
Anthropic Settles High-Profile AI Copyright Lawsuit Brought by Book Authors
Next article
Anthropic launches Claude for Chrome in limited beta, but prompt injection attacks remain a major concern

© AmericanJuggalo.com | All Rights Reserved.